Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9711753rdf:typepubmed:Citationlld:pubmed
pubmed-article:9711753lifeskim:mentionsumls-concept:C0032005lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C1609982lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C1979893lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C1273404lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C0205265lld:lifeskim
pubmed-article:9711753lifeskim:mentionsumls-concept:C1555582lld:lifeskim
pubmed-article:9711753pubmed:issue1-4 Pt 2lld:pubmed
pubmed-article:9711753pubmed:dateCreated1998-11-13lld:pubmed
pubmed-article:9711753pubmed:abstractTextWe describe our initial experience with fractionated stereotactic radiotherapy (SRT) for the treatment of 19 patients with secretory and nonsecretory pituitary macroadenomas. The primary endpoints of local control and the documentation of any MRI T2-weighted changes in contiguous brain tissues are discussed.lld:pubmed
pubmed-article:9711753pubmed:languageenglld:pubmed
pubmed-article:9711753pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9711753pubmed:citationSubsetIMlld:pubmed
pubmed-article:9711753pubmed:statusMEDLINElld:pubmed
pubmed-article:9711753pubmed:issn1011-6125lld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:AndrewsD WDWlld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:DowneyDDlld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:CurranW JWJJrlld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:CornB WBWlld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:McCuneCClld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:Werner-WasikM...lld:pubmed
pubmed-article:9711753pubmed:authorpubmed-author:CokeCClld:pubmed
pubmed-article:9711753pubmed:issnTypePrintlld:pubmed
pubmed-article:9711753pubmed:volume69lld:pubmed
pubmed-article:9711753pubmed:ownerNLMlld:pubmed
pubmed-article:9711753pubmed:authorsCompleteYlld:pubmed
pubmed-article:9711753pubmed:pagination183-90lld:pubmed
pubmed-article:9711753pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:meshHeadingpubmed-meshheading:9711753-...lld:pubmed
pubmed-article:9711753pubmed:year1997lld:pubmed
pubmed-article:9711753pubmed:articleTitleMultiple fractionated stereotactic radiotherapy of residual pituitary macroadenomas: initial experience.lld:pubmed
pubmed-article:9711753pubmed:affiliationJefferson Medical College, Thomas Jefferson University, Philadelphia, Pa., USA.lld:pubmed
pubmed-article:9711753pubmed:publicationTypeJournal Articlelld:pubmed